MCAT Biological and Biochemical Foundations of Living Systems Quiz: 1d Glycolysis Gluconeogenesis Ppp
20 questions · exam conditions
0:00
1d Glycolysis Gluconeogenesis PppQuestion 1 of 20

A study of rapidly dividing cells (150–250 words) reported increased demand for ribose-5-phosphate (R5P) for nucleotide synthesis. Investigators observed increased flux through the non-oxidative PPP while NADPH levels remained unchanged. They proposed carbon rearrangement reactions were favored without net oxidation.

Context: non-oxidative PPP interconverts glycolytic intermediates ↔\leftrightarrow R5P

Based on the scenario, which outcome is most consistent with increased non-oxidative PPP flux (with unchanged oxidative PPP)?

Increased ATP yield because non-oxidative PPP includes the phosphoglycerate kinase step
Increased NADPH because non-oxidative PPP contains the primary NADPH-generating dehydrogenase
Decreased R5P because non-oxidative PPP irreversibly consumes pentoses to make lactate
Increased R5P availability without a proportional increase in NADPH production
← Back to quizzes

MCAT Biological and Biochemical Foundations of Living Systems Quiz

MCAT Biological and Biochemical Foundations of Living Systems Quiz: 1d Glycolysis Gluconeogenesis Ppp

Practice 1d Glycolysis Gluconeogenesis Ppp in MCAT Biological and Biochemical Foundations of Living Systems with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on 1d Glycolysis Gluconeogenesis Ppp, giving you a quick way to practice the rules, question types, and explanations that matter most for MCAT Biological and Biochemical Foundations of Living Systems.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A study of rapidly dividing cells (150–250 words) reported increased demand for ribose-5-phosphate (R5P) for nucleotide synthesis. Investigators observed increased flux through the non-oxidative PPP while NADPH levels remained unchanged. They proposed carbon rearrangement reactions were favored without net oxidation.

Context: non-oxidative PPP interconverts glycolytic intermediates ↔\leftrightarrow R5P

Based on the scenario, which outcome is most consistent with increased non-oxidative PPP flux (with unchanged oxidative PPP)?

  1. Increased ATP yield because non-oxidative PPP includes the phosphoglycerate kinase step
  2. Increased NADPH because non-oxidative PPP contains the primary NADPH-generating dehydrogenase
  3. Decreased R5P because non-oxidative PPP irreversibly consumes pentoses to make lactate
  4. Increased R5P availability without a proportional increase in NADPH production (correct answer)

Explanation: This question tests the non-oxidative PPP's role in ribose production. Non-oxidative PPP rearranges carbons to generate ribose-5-phosphate (R5P) without NADPH production, meeting nucleotide demands. In these dividing cells, increased non-oxidative flux provides R5P while NADPH remains unchanged, decoupling from oxidative phase. Choice D is correct because it describes increased R5P without proportional NADPH, fitting biosynthetic needs. Choice B fails by attributing NADPH to non-oxidative PPP, which lacks dehydrogenases. For similar questions, distinguish oxidative and non-oxidative branches. Verify if flux matches cellular demands like proliferation.

Question 2

A liver perfusion protocol (150–250 words) compared two conditions with equal glucose availability: (i) high ATP/high citrate and (ii) low ATP/high AMP. Investigators monitored the rate of fructose-1,6-bisphosphate formation from fructose-6-phosphate and found it was higher in condition (ii). No changes in enzyme abundance occurred over the time course.

Control point: Fructose-6-phosphate →PFK-1\xrightarrow{\textit{PFK-1}} Fructose-1,6-bisphosphate

Based on the scenario, which regulatory interpretation is most consistent with the observed flux difference?

  1. Increased PFK-1 flux occurs because fructose-1,6-bisphosphate is a mandatory PPP intermediate
  2. Allosteric activation of PFK-1 by ATP under high-energy conditions increases glycolysis
  3. Inhibition of PFK-1 by AMP favors glycolysis by removing a rate-limiting step
  4. Allosteric activation of PFK-1 by AMP under low-energy conditions increases glycolytic commitment (correct answer)

Explanation: This question tests allosteric regulation of PFK-1 in glycolysis. PFK-1 is activated by AMP in low-energy states to promote glycolytic ATP production. In this perfusion, low ATP/high AMP (condition ii) activates PFK-1, increasing fructose-1,6-bisphosphate formation compared to high-energy condition. Choice D is correct because it links AMP activation to increased glycolytic commitment under low energy. Choice B fails by incorrectly attributing activation to ATP, which actually inhibits PFK-1. For similar questions, compare effector impacts on enzyme kinetics. Verify energy status alignment with regulatory logic.

Question 3

A genetic study (150–250 words) described a rare loss-of-function mutation in pyruvate kinase restricted to red blood cells. Patients had hemolytic anemia, but leukocyte counts were normal. In vitro assays of patient erythrocytes showed reduced conversion of phosphoenolpyruvate to pyruvate and reduced ATP levels; oxidative PPP enzyme activities were normal.

Reaction: Phosphoenolpyruvate + ADP →pyruvate kinase\xrightarrow{\textit{pyruvate kinase}} Pyruvate + ATP

Which prediction is most aligned with the described mutation?

  1. Increased ATP generation because impaired glycolysis increases oxidative phosphorylation in erythrocytes
  2. Decreased erythrocyte ATP due to impaired substrate-level phosphorylation at the pyruvate kinase step (correct answer)
  3. Decreased NADPH because pyruvate kinase catalyzes the first oxidative PPP step
  4. Increased gluconeogenesis in erythrocytes to compensate for reduced glycolysis

Explanation: This question tests the role of pyruvate kinase in glycolytic ATP production. Pyruvate kinase generates ATP via substrate-level phosphorylation in the final glycolytic step. In these mutant erythrocytes, pyruvate kinase deficiency impairs ATP production, contributing to hemolytic anemia despite normal PPP. Choice B is correct because it explains decreased ATP from blocked substrate-level phosphorylation. Choice A fails by suggesting increased oxidative phosphorylation, but erythrocytes lack mitochondria. For similar questions, identify ATP-yielding steps in anaerobic pathways. Verify cell-type constraints like absence of mitochondria.

Question 4

Erythrocytes from a cohort with chronic hemolysis showed markedly reduced NADPH/NADP+^+ ratio at baseline. Sequencing identified a missense variant in glucose-6-phosphate dehydrogenase that decreases catalytic efficiency but does not change enzyme abundance. Under an oxidant challenge ex vivo, cells exhibited increased methemoglobin formation.

Which prediction is most aligned with the described mutation in the oxidative phase of the pentose phosphate pathway (PPP)?

  1. Increased ribose-5-phosphate production with increased NADPH generation per glucose-6-phosphate
  2. Decreased NADPH availability leading to impaired regeneration of reduced glutathione (GSH) (correct answer)
  3. Increased cytosolic ATP production because PPP directly produces ATP in its oxidative steps
  4. Increased gluconeogenic flux because glucose-6-phosphate dehydrogenase inhibition activates glucose-6-phosphatase

Explanation: This question tests understanding of the pentose phosphate pathway's oxidative phase and its role in generating NADPH. Glucose-6-phosphate dehydrogenase (G6PD) catalyzes the rate-limiting step of the oxidative PPP, converting glucose-6-phosphate to 6-phosphogluconolactone while reducing NADP+ to NADPH. A mutation decreasing G6PD catalytic efficiency would reduce NADPH production, impairing the cell's ability to regenerate reduced glutathione (GSH) from oxidized glutathione (GSSG). This leaves erythrocytes vulnerable to oxidative damage, explaining the increased methemoglobin formation under oxidant challenge. Choice A incorrectly suggests increased NADPH generation, while choice C wrongly claims the PPP produces ATP. For PPP questions, remember that the oxidative phase generates NADPH (not ATP) for reductive biosynthesis and antioxidant defense.

Question 5

A fasting-state clamp study in healthy volunteers compared hepatic metabolite profiles at baseline (12 h fast) versus during infusion of glucagon (physiologic range) with stable plasma glucose. Within 20 min, hepatic citrate increased and cytosolic ATP/AMP increased, while lactate output from the liver decreased. The investigators focused on a rate-limiting glycolytic step sensitive to cellular energy charge.

Which outcome is most consistent with increased allosteric inhibition of PFK-1 under these conditions?

  1. Accumulation of fructose-6-phosphate with decreased formation of fructose-1,6-bisphosphate (correct answer)
  2. Decreased fructose-6-phosphate with increased formation of fructose-1,6-bisphosphate
  3. Increased conversion of pyruvate to oxaloacetate by pyruvate carboxylase as a direct consequence of PFK-1 activation
  4. Increased net ATP yield per glucose in glycolysis from 2 ATP to 4 ATP due to PFK-1 inhibition

Explanation: This question tests understanding of PFK-1 regulation by energy charge. PFK-1 is allosterically inhibited by ATP and citrate (indicators of high energy status) and activated by AMP and ADP (low energy indicators). In the fasting state with glucagon signaling, increased hepatic citrate and ATP/AMP ratio would strongly inhibit PFK-1. When PFK-1 is inhibited, its substrate fructose-6-phosphate accumulates while its product fructose-1,6-bisphosphate decreases, effectively blocking glycolytic flux. Choice B incorrectly reverses the substrate-product relationship, while choice D wrongly claims PFK-1 inhibition increases ATP yield. Remember that PFK-1 inhibition causes upstream substrate accumulation and downstream product depletion, consistent with reduced glycolytic flux during energy-replete states.

Question 6

A tumor cell line was engineered to overexpress pyruvate kinase M2 (PKM2) locked in a high-activity tetrameric state. Under normoxia with abundant glucose, the modified cells showed decreased accumulation of upstream glycolytic intermediates used for biosynthesis.

Which outcome is most consistent with increased pyruvate kinase activity in this context?

  1. Increased phosphoenolpyruvate (PEP) levels due to reduced conversion of PEP to pyruvate
  2. Decreased pyruvate formation with decreased substrate-level phosphorylation in glycolysis
  3. Increased conversion of PEP to pyruvate with increased ATP generation at the pyruvate kinase step (correct answer)
  4. Increased net NADPH production because pyruvate kinase is a regulatory enzyme of the oxidative PPP

Explanation: This question tests understanding of pyruvate kinase's role in glycolysis and metabolic flux. Pyruvate kinase catalyzes the final ATP-generating step of glycolysis, converting phosphoenolpyruvate (PEP) to pyruvate. When PKM2 is locked in its high-activity tetrameric state, it efficiently converts PEP to pyruvate, generating ATP and preventing accumulation of upstream glycolytic intermediates. This increased flux through the terminal glycolytic step reduces the availability of intermediates for biosynthetic pathways (like serine synthesis from 3-phosphoglycerate). Choice A incorrectly suggests PEP accumulation, while choice D wrongly connects pyruvate kinase to the PPP. For metabolic flux questions, remember that increasing enzyme activity at a regulatory step pulls substrates through that reaction, depleting upstream intermediates.

Question 7

In a hepatocyte perfusion study (journal-style, 2 h), investigators increased intracellular AMP using a nonhydrolyzable analog while maintaining constant extracellular glucose (5 mM) and oxygenation. They quantified glycolytic flux by lactate release and reported a rapid increase in fructose-2,6-bisphosphate (F2,6BP) with no change in total PFK-2/FBPase-2 protein. The authors propose an allosteric mechanism that increases glycolysis under low-energy conditions.

Based on this scenario, which metabolic shift would be expected to be most consistent with increased F2,6BP in hepatocytes?

  1. Decreased activity of PFK-1 with reduced conversion of fructose-6-phosphate to fructose-1,6-bisphosphate
  2. Increased activity of PFK-1 with increased conversion of fructose-6-phosphate to fructose-1,6-bisphosphate (correct answer)
  3. Increased activity of hepatic fructose-1,6-bisphosphatase with increased gluconeogenic flux to glucose
  4. Increased mitochondrial localization of PFK-1, enhancing ATP production via oxidative phosphorylation

Explanation: This question tests understanding of glycolytic regulation through fructose-2,6-bisphosphate (F2,6BP) signaling. F2,6BP is a potent allosteric activator of phosphofructokinase-1 (PFK-1) and inhibitor of fructose-1,6-bisphosphatase, making it a key regulator that promotes glycolysis and inhibits gluconeogenesis. When AMP levels increase (indicating low energy status), PFK-2/FBPase-2 is activated in its kinase form, producing more F2,6BP. This increased F2,6BP then activates PFK-1, leading to increased conversion of fructose-6-phosphate to fructose-1,6-bisphosphate and enhanced glycolytic flux. Choice C incorrectly suggests gluconeogenic activation, which would be inhibited by F2,6BP. To identify correct regulatory mechanisms, always consider that F2,6BP promotes glycolysis (activates PFK-1) and inhibits gluconeogenesis (inhibits FBPase-1).

Question 8

In a hepatocyte perfusion study (150–250 words), investigators clamped cytosolic ATP at a low level while maintaining constant glucose-6-phosphate (G6P). They observed a rapid increase in fructose-2,6-bisphosphate (F2,6BP) and a decrease in net glucose output. The intervention did not alter mitochondrial substrate availability. A simplified scheme was used:

Flow: Fructose-6-phosphate ⇌FBPase-2PFK-2\xrightleftharpoons[\textit{FBPase-2}]{\textit{PFK-2}} F2,6BP →\rightarrow modulation of glycolysis/gluconeogenesis

Assuming the dominant acute control point is the bifunctional enzyme PFK-2/FBPase-2, which prediction is most consistent with increased PFK-2 kinase activity under these low-energy conditions?

  1. Increased cytosolic citrate and increased flux through gluconeogenesis via activation of FBPase-1
  2. Decreased F2,6BP and decreased glycolytic flux due to inhibition of PFK-1
  3. Increased F2,6BP with increased PFK-1 activity and reduced net gluconeogenic flux (correct answer)
  4. Increased ATP yield per glucose because F2,6BP directly increases substrate-level phosphorylation steps

Explanation: This question tests the regulation of glycolysis and gluconeogenesis by fructose-2,6-bisphosphate (F2,6BP). F2,6BP is produced by the kinase activity of the bifunctional enzyme PFK-2/FBPase-2 and acts as a potent activator of PFK-1 while inhibiting FBPase-1. In this hepatocyte study with low ATP, increased PFK-2 kinase activity elevates F2,6BP, favoring glycolysis over gluconeogenesis and reducing net glucose output. Choice C is correct because increased F2,6BP enhances PFK-1 activity, promoting glycolysis and decreasing gluconeogenic flux, consistent with the observed decrease in glucose output. Choice A fails because it misattributes activation to citrate, which is not the primary regulator here and would typically signal high energy, not low. For similar questions, identify the energy status and its effect on PFK-2/FBPase-2 phosphorylation state. Always verify if the regulator aligns with promoting glycolysis in low-energy conditions.

Question 9

A fasting-state mouse model (150–250 words) was engineered to express a liver-specific variant of fructose-1,6-bisphosphatase (FBPase-1) that is resistant to inhibition by AMP. During a 16-hour fast, hepatic ATP and AMP levels were measured and found to be low ATP/high AMP compared with wild-type, yet plasma glucose remained elevated. No changes were observed in glucagon receptor signaling.

Reaction context: Fructose-1,6-bisphosphate →FBPase-1\xrightarrow{\textit{FBPase-1}} Fructose-6-phosphate (gluconeogenesis)

Which prediction is most aligned with the described mutation?

  1. Reduced hepatic gluconeogenesis because high AMP will still inhibit FBPase-1 and favor glycolysis
  2. Increased hepatic gluconeogenic flux despite high AMP, promoting continued glucose output during fasting (correct answer)
  3. Increased PPP oxidative flux because FBPase-1 is the rate-limiting enzyme of NADPH production
  4. Decreased cytosolic NADH because FBPase-1 directly consumes NADH in its catalytic step

Explanation: This question tests the regulation of gluconeogenesis by allosteric inhibitors at key enzymes. AMP inhibits FBPase-1, a rate-limiting enzyme in gluconeogenesis, to prevent futile cycling during low-energy states. In this mouse model, the AMP-resistant FBPase-1 mutation allows gluconeogenesis to proceed despite high AMP, maintaining glucose output. Choice B is correct because the mutation bypasses AMP inhibition, increasing gluconeogenic flux and sustaining plasma glucose during fasting. Choice A fails due to misunderstanding that high AMP would still inhibit the mutated enzyme, but the variant is resistant. In similar questions, check for mutations altering allosteric sites and their impact on pathway flux. Verify if the change favors the pathway's continuation under inhibitory conditions.

Question 10

A mitochondrial function clamp (150–250 words) in hepatocytes held oxidative phosphorylation constant while manipulating cytosolic redox state. When cytosolic NADH was increased, investigators observed reduced net conversion of lactate to glucose, despite unchanged activities of PEPCK and FBPase-1. They concluded that the redox shift altered the directionality of the lactate/pyruvate interconversion.

Relevant step: Pyruvate + NADH ⇌LDH\xrightleftharpoons[\textit{LDH}]{} Lactate + NAD+^+

Based on the scenario, which prediction is most consistent with increased cytosolic NADH?

  1. Shift toward lactate formation, decreasing pyruvate availability for gluconeogenesis from lactate (correct answer)
  2. Shift toward pyruvate formation, increasing gluconeogenesis from lactate
  3. Increased NADPH production because cytosolic NADH directly activates oxidative PPP dehydrogenases
  4. Increased ATP yield because NADH is directly converted to ATP in the cytosol without mitochondria

Explanation: This question tests redox regulation of lactate-pyruvate equilibrium. High cytosolic NADH favors lactate formation via LDH, reducing pyruvate available for gluconeogenesis. In these hepatocytes, increased NADH shifts equilibrium toward lactate, decreasing glucose from lactate precursors. Choice A is correct because it predicts a shift to lactate, limiting gluconeogenic substrate. Choice B fails by suggesting increased pyruvate, reversing the redox effect. In similar questions, apply mass action to reversible reactions. Check if redox state influences pathway directionality.

Question 11

In a cancer cell line (150–250 words) under normoxia, investigators observed high rates of glucose uptake and lactate secretion. They also measured elevated cytosolic NADPH and increased incorporation of glucose carbon into fatty acids. A selective activator of glucose-6-phosphate dehydrogenase (G6PD) further increased NADPH without changing ATP.

PPP entry: G6P →G6PD\xrightarrow{\textit{G6PD}} 6-phosphogluconolactone + NADPH

Based on the scenario, which metabolic shift would be expected upon increasing G6PD activity?

  1. Increased ATP production because oxidative PPP produces 22 ATP per G6P at its first step
  2. Reduced NADPH because increased G6PD consumes NADPH as a substrate
  3. Increased net gluconeogenesis because oxidative PPP is required to produce glucose
  4. Greater diversion of G6P into oxidative PPP to support reductive biosynthesis via NADPH (correct answer)

Explanation: This question tests the function of the oxidative PPP in biosynthetic support. G6PD initiates the oxidative PPP, producing NADPH for reductive processes like fatty acid synthesis. In these cancer cells, G6PD activation increases NADPH and diverts G6P into PPP, supporting lipid biosynthesis without affecting ATP. Choice D is correct because it explains greater PPP diversion for NADPH-dependent biosynthesis. Choice B fails by stating G6PD consumes NADPH, confusing product with substrate. For similar questions, link PPP flux to cellular demands like proliferation. Verify if the pathway generates reducing equivalents versus energy.

Question 12

A metabolite clamp study (150–250 words) in hepatocytes maintained high acetyl-CoA while varying pyruvate availability. Under high acetyl-CoA, conversion of pyruvate to oxaloacetate increased, supporting glucose production from lactate. The investigators focused on acute allosteric regulation at the mitochondrial entry point of gluconeogenesis.

Key step: Pyruvate + CO2_2 + ATP →pyruvate carboxylase\xrightarrow{\textit{pyruvate carboxylase}} Oxaloacetate

Which prediction is most consistent with increased pyruvate carboxylase activity in this context?

  1. Increased NADPH production because pyruvate carboxylase reduces NADP+^+
  2. Decreased gluconeogenesis because increased oxaloacetate directly inhibits all downstream steps
  3. Enhanced gluconeogenic capacity from pyruvate because oxaloacetate formation is increased (correct answer)
  4. Increased ATP yield because pyruvate carboxylase produces ATP during carboxylation

Explanation: This question tests allosteric activation of gluconeogenesis entry. Acetyl-CoA activates pyruvate carboxylase, enhancing oxaloacetate formation for gluconeogenesis. In these hepatocytes, high acetyl-CoA increases pyruvate carboxylase activity, supporting glucose production from pyruvate-derived substrates. Choice C is correct because it predicts enhanced gluconeogenic capacity via increased oxaloacetate. Choice B fails by suggesting inhibition, confusing acetyl-CoA's activator role. In similar questions, identify allosteric effectors from related pathways. Check if the activator signals substrate abundance for the pathway.

Question 13

A liver-directed gene therapy (150–250 words) increased expression of glucose-6-phosphatase in hepatocytes. In the fasting state, treated animals showed increased plasma glucose and decreased hepatic glucose-6-phosphate (G6P) levels compared with controls; glycolytic lactate production decreased. The investigators emphasized the terminal step of gluconeogenesis/glycogenolysis.

Key step: G6P →glucose-6-phosphatase\xrightarrow{\textit{glucose-6-phosphatase}} Glucose + Pi_i

Which prediction is most aligned with increased glucose-6-phosphatase activity in liver during fasting?

  1. Increased hepatic glucose export due to enhanced conversion of G6P to free glucose (correct answer)
  2. Decreased plasma glucose because glucose-6-phosphatase traps glucose in cells as G6P
  3. Increased NADPH production because glucose-6-phosphatase is the oxidative PPP rate-limiting enzyme
  4. Increased ATP yield because hydrolysis of G6P directly generates ATP in the cytosol

Explanation: This question tests the terminal step of hepatic glucose release. Glucose-6-phosphatase hydrolyzes G6P to free glucose, enabling export during fasting. In this therapy, increased enzyme activity depletes hepatic G6P, enhancing glucose output and reducing glycolysis. Choice A is correct because it explains increased export via efficient G6P conversion. Choice B fails by suggesting trapping as G6P, confusing the enzyme's hydrolytic function. In similar questions, identify unique hepatic enzymes for glucose homeostasis. Check for effects on intracellular metabolites and plasma levels.

Question 14

A red blood cell metabolomics dataset (150–250 words) showed that after oxidative challenge, one sample accumulated 6-phosphogluconate while producing less NADPH than controls. Glycolytic intermediates downstream of glyceraldehyde-3-phosphate were unchanged. Enzyme activity measurements indicated reduced 6-phosphogluconate dehydrogenase activity.

PPP oxidative step: 6-phosphogluconate + NADP+^+ →6PGD\xrightarrow{\textit{6PGD}} ribulose-5-phosphate + NADPH + CO2_2

Which prediction is most aligned with this deficiency?

  1. Decreased NADPH generation in oxidative PPP with buildup of 6-phosphogluconate (correct answer)
  2. Increased NADH generation because 6-phosphogluconate dehydrogenase reduces NAD+^+
  3. Increased ATP production because blocking oxidative PPP forces more substrate-level phosphorylation
  4. Increased gluconeogenesis because oxidative PPP is required for hepatic glucose export

Explanation: This question tests the oxidative phase of the PPP and NADPH production. 6-Phosphogluconate dehydrogenase generates NADPH and CO2 in the second oxidative step of PPP. In these red blood cells, its deficiency causes 6-phosphogluconate accumulation and reduced NADPH, impairing redox defense. Choice A is correct because it predicts decreased NADPH with intermediate buildup in oxidative PPP. Choice B fails by stating it reduces NAD+ instead of NADP+, confusing cofactors. In similar questions, sequence PPP steps and cofactor outputs. Check for specific metabolite accumulations to pinpoint the defect.

Question 15

A hepatocyte tracer experiment (150–250 words) used [2-13^{13}C]glycerol during a 24-hour fast. Investigators observed incorporation of label into glucose, indicating active gluconeogenesis. When a selective inhibitor of cytosolic phosphoenolpyruvate carboxykinase (PEPCK) was added, glucose production dropped markedly, while pyruvate and oxaloacetate-derived intermediates accumulated.

Reaction context: Oxaloacetate →PEPCK\xrightarrow{\textit{PEPCK}} Phosphoenolpyruvate (gluconeogenesis)

Which prediction is most aligned with pharmacologic inhibition of PEPCK during fasting?

  1. Increased hepatic glucose output because blocking PEPCK forces glycolysis to run in reverse
  2. Decreased gluconeogenic flux from three-carbon substrates due to impaired formation of phosphoenolpyruvate (correct answer)
  3. Increased NADPH production because PEPCK generates NADPH in the oxidative PPP
  4. Increased ATP yield per glycerol because PEPCK inhibition removes a GTP-consuming step

Explanation: This question tests the role of PEPCK in gluconeogenesis. PEPCK converts oxaloacetate to phosphoenolpyruvate, a key irreversible step in gluconeogenesis from three-carbon precursors. In this experiment, PEPCK inhibition blocks phosphoenolpyruvate formation, reducing glucose production and causing upstream intermediate accumulation. Choice B is correct because it describes decreased gluconeogenic flux from substrates like glycerol due to impaired PEPCK activity. Choice A fails by suggesting increased flux, ignoring the block at this committed step. In similar questions, trace carbon flow and identify bottleneck enzymes. Check for label incorporation patterns to confirm pathway disruption.

Question 16

During an acute sprint protocol, skeletal muscle biopsies showed increased AMP and decreased pH (increased H+^+). Investigators focused on the rate-limiting glycolytic enzyme PFK-1, noting that AMP rose while H+^+ also rose due to lactate-associated acidification. The measured net glycolytic flux increased initially but plateaued despite further rises in AMP. The relevant regulatory step was:

F6P --(PFK-1)→ F1,6BP

Based on the scenario, which explanation is most consistent with the plateau in glycolytic flux?

  1. High H+^+ counteracts activation by AMP by inhibiting PFK-1, limiting further flux increases (correct answer)
  2. AMP inhibits PFK-1, preventing continued glycolysis despite high energy demand
  3. Rising H+^+ activates PFK-1 and should prevent any plateau in flux
  4. The plateau occurs because PFK-1 is located in mitochondria and becomes substrate-limited by oxygen

Explanation: This question tests understanding of competing allosteric regulation of phosphofructokinase-1 (PFK-1) during exercise. PFK-1 is allosterically activated by AMP (signaling energy depletion) but inhibited by H+ (protons from lactate-associated acidification). During intense exercise, both regulators increase: AMP rises due to ATP breakdown, while H+ rises from lactate accumulation. Initially, AMP activation dominates, increasing glycolytic flux. However, as exercise continues and acidification worsens, H+ inhibition increasingly counteracts AMP activation, causing flux to plateau despite continued energy demand. The correct answer (A) accurately describes H+ counteracting AMP activation to limit flux increases. Option C incorrectly states that H+ activates PFK-1 when it actually inhibits it. To analyze complex regulation, consider that multiple allosteric effectors can have opposing effects, with the net outcome depending on their relative concentrations and potencies.

Question 17

A tumor cell line is engineered to overexpress cytosolic pyruvate kinase (PK) while maintaining the same glucose uptake rate. In culture, oxygen is sufficient, but the cells exhibit increased lactate secretion and decreased incorporation of glucose-derived carbon into biosynthetic pathways.

Which outcome is most consistent with increased PK activity in this context?

  1. Decreased conversion of phosphoenolpyruvate to pyruvate, causing accumulation of phosphoenolpyruvate
  2. Increased diversion of glucose-6-phosphate into the oxidative PPP, increasing NADPH production
  3. Increased net ATP generation at the phosphoenolpyruvate step, with increased pyruvate availability for lactate formation (correct answer)
  4. Increased gluconeogenesis because PK is a key enzyme of hepatic glucose production

Explanation: This question tests understanding of pyruvate kinase (PK) regulation and metabolic flux control. PK catalyzes the final ATP-generating step of glycolysis, converting phosphoenolpyruvate to pyruvate. Overexpressing PK increases the conversion of PEP to pyruvate, generating ATP and increasing pyruvate availability. With constant glucose uptake but increased PK activity, more glucose carbon flows through glycolysis to pyruvate rather than being diverted to biosynthetic pathways. The excess pyruvate is converted to lactate even with sufficient oxygen (aerobic glycolysis or Warburg effect), explaining increased lactate secretion. Choice A incorrectly suggests PK overexpression decreases its own activity, choice B wrongly connects PK to PPP regulation, and choice D mistakenly identifies PK as a gluconeogenic enzyme. To analyze metabolic engineering effects, trace how altered enzyme activity affects substrate availability for competing pathways.

Question 18

In hepatocytes, investigators pharmacologically increased cytosolic citrate concentration while holding ATP and AMP constant. They observed a rapid decrease in glycolytic flux and a rise in upstream hexose phosphates.

Which outcome is most consistent with citrate-mediated regulation in this setting?

  1. Allosteric inhibition of phosphofructokinase-1, decreasing fructose-1,6-bisphosphate formation (correct answer)
  2. Allosteric activation of phosphofructokinase-1, increasing fructose-1,6-bisphosphate formation
  3. Direct activation of glucose-6-phosphate dehydrogenase, increasing CO2_2 release from the oxidative PPP
  4. Direct inhibition of fructose-1,6-bisphosphatase, decreasing gluconeogenesis and increasing lactate release

Explanation: This question tests understanding of citrate as an allosteric regulator of glycolysis. Citrate is a key allosteric inhibitor of phosphofructokinase-1 (PFK-1), the committed step of glycolysis that converts fructose-6-phosphate to fructose-1,6-bisphosphate. High cytosolic citrate indicates sufficient biosynthetic precursors and energy status, signaling to decrease glycolytic flux. When citrate inhibits PFK-1, fructose-1,6-bisphosphate formation decreases, causing upstream hexose phosphates (glucose-6-phosphate and fructose-6-phosphate) to accumulate. This regulatory mechanism prevents excessive glycolysis when citrate cycle intermediates are abundant. Choice B incorrectly states citrate activates PFK-1, choice C wrongly connects citrate to G6PD regulation, and choice D confuses the effects on different pathways. To identify allosteric regulation patterns, remember that citrate, ATP, and H+ inhibit PFK-1, while AMP, ADP, and fructose-2,6-bisphosphate activate it.

Question 19

In isolated hepatocytes maintained at constant extracellular glucose (5 mM), investigators perfused cells with a membrane-permeable AMP analog that increased cytosolic AMP without changing oxygen availability. Within 10 minutes, lactate release increased while net hepatic glucose output decreased. The group hypothesized that altered allosteric regulation of a single rate-limiting glycolytic step best explains both findings under these conditions.

Which outcome is most consistent with increased activity of phosphofructokinase-1 (PFK-1) in response to elevated AMP?

(Assume downstream enzymes are not limiting over this short time window.)

  1. Increased fructose-2,6-bisphosphate synthesis by fructose-2,6-bisphosphatase, lowering glycolytic flux
  2. Decreased fructose-1,6-bisphosphate formation, with accumulation of fructose-6-phosphate
  3. Increased conversion of fructose-6-phosphate to fructose-1,6-bisphosphate, increasing pyruvate and lactate formation (correct answer)
  4. Increased hepatic glucose output due to stimulation of gluconeogenesis at the PFK-1 step

Explanation: This question tests understanding of allosteric regulation of phosphofructokinase-1 (PFK-1) in glycolysis. PFK-1 catalyzes the committed step of glycolysis (fructose-6-phosphate to fructose-1,6-bisphosphate) and is allosterically activated by AMP, a signal of low energy status. In the scenario, elevated AMP would activate PFK-1, increasing the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate, which drives glycolytic flux forward. This increased glycolytic flux produces more pyruvate, which under constant oxygen conditions gets converted to lactate, explaining the increased lactate release. The decreased hepatic glucose output occurs because increased glycolysis consumes glucose-6-phosphate, reducing substrate availability for glucose-6-phosphatase and thus glucose release. Choice A incorrectly names fructose-2,6-bisphosphatase (which would decrease F2,6BP), and choice D wrongly suggests PFK-1 stimulates gluconeogenesis when it actually opposes it.

Question 20

A cell-free cytosolic extract from human erythrocytes was supplied with glucose-6-phosphate (G6P) as the only carbon input. Under condition 1, NADP+^+ was abundant; under condition 2, NADPH was added to raise the NADPH/NADP+^+ ratio while keeping total NADP(H) constant. All other substrates and cofactors were unchanged.

The investigators monitored CO2_2 release from the oxidative branch of the pentose phosphate pathway (PPP) over 5 minutes.

Based on the scenario, which metabolic shift would be expected when the NADPH/NADP+^+ ratio is increased?

  1. Increased oxidative PPP flux due to activation of glucose-6-phosphate dehydrogenase by NADPH
  2. Decreased oxidative PPP flux because glucose-6-phosphate dehydrogenase is inhibited by NADPH (correct answer)
  3. Increased glycolytic ATP yield from G6P because the oxidative PPP generates 44 ATP per G6P
  4. Increased mitochondrial NADH production because the oxidative PPP occurs in the mitochondrial matrix

Explanation: This question tests understanding of feedback inhibition in the oxidative pentose phosphate pathway (PPP). Glucose-6-phosphate dehydrogenase (G6PD) catalyzes the rate-limiting step of the oxidative PPP, converting G6P to 6-phosphoglucono-δ-lactone while reducing NADP+ to NADPH. G6PD is strongly inhibited by its product NADPH through negative feedback regulation. When the NADPH/NADP+ ratio is increased (condition 2), G6PD activity decreases, reducing flux through the oxidative PPP and thus decreasing CO2 release from the decarboxylation steps. This regulatory mechanism ensures NADPH production matches cellular needs. Choice A incorrectly states NADPH activates G6PD, choice C wrongly claims the PPP generates ATP, and choice D incorrectly places the oxidative PPP in mitochondria when it occurs in the cytosol. To identify similar regulatory patterns, look for product inhibition of rate-limiting enzymes in biosynthetic pathways.